연구동향 분석

항암제 과민반응에 대한 탈감작요법의 최신지견

이서영 ( Suh Young Lee ) 양민석 ( Min Suk Yang ) 정재우 ( Jae Woo Jung ) 오미정 ( Mi Jung Oh ) 박창한 ( Chang Han Park ) 손성욱 ( Seong Wook Sohn ) 강혜련 ( Hye Ryun Kang ) 조영주 ( Young Joo Cho ) 2014년

논문상세정보
인용/피인용
' 항암제 과민반응에 대한 탈감작요법의 최신지견' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,252 0

0.0%

' 항암제 과민반응에 대한 탈감작요법의 최신지견' 의 참고문헌

  • the drawbacks and advantages of vehicle selection for drug formulation
    Gelderblom H Eur J Cancer 37 : 1590 ~ 1598 [2001]
  • Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer
    Callahan MB Am J Obstet Gynecol 197 : 199 ~ [2007]
  • Update on taxane development: new analogs and new formulations
    Yared JA Drug Des Devel Ther 6 : 371 ~ 384 [2012]
  • The impact of neo-osteogenesis on disease control in chronic rhinosinusitis after primary surgery
    Sacks PL Int Forum Allergy Rhinol 3 : 823 ~ 827 [2013]
  • The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization
    Pagani M Med Clin North Am 94 : 835 ~ 852 [2010]
  • Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial
    Rothenberg ML J Clin Oncol 21 : 2059 ~ 2069 [2003]
  • Successful re-treatment with taxol after major hypersensitivity reactions
    Peereboom DM J Clin Oncol 11 : 885 ~ 890 [1993]
  • Successful parenteral desensitization to paclitaxel
    Essayan DM J Allergy Clin Immunol 97 : 42 ~ 46 [1996]
  • Successful desensitization to oxaliplatin
    Mis L Ann Pharmacother 39 : 966 ~ 969 [2005]
  • Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses
    Lee CW Gynecol Oncol 99 : 393 ~ 399 [2005]
  • Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments
    Feldweg AM Gynecol Oncol 96 : 824 ~ 829 [2005]
  • Rapid desensitization for L-asparaginase hypersensitivity
    Bonno M J Allergy Clin Immunol 101 : 571 ~ 572 [1998]
  • Prevention and handling of acute allergic and infusion reactions in oncology
    Joerger M Ann Oncol 23 : 313 ~ 319 [2012]
  • Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
    Wani MC J Am Chem Soc 93 : 2325 ~ 2327 [1971]
  • Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
    Gradishar WJ J Clin Oncol 23 : 7794 ~ 7803 [2005]
  • Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center
    Markman M J Clin Oncol 18 : 102 ~ 105 [2000]
  • Paclitaxel hypersensitivity reactions: a role for docetaxel substitution
    Lokich J Ann Oncol 9 : 573 ~ [1998]
  • Paclitaxel (taxol)
    Rowinsky EK N Engl J Med 332 : 1004 ~ 1014 [1995]
  • Nonallergic drug hypersensitivity reactions
    Farnam K Int Arch Allergy Immunol 159 : 327 ~ 345 [2012]
  • Immunohemolytic anemia following oxaliplatin administration
    Garufi C Ann Oncol 11 : 497 ~ [2000]
  • IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps
    Shaw JL Am J Respir Crit Care Med 188 : 432 ~ 439 [2013]
  • Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization
    Castells M Cancer Immunol Immunother 61 : 1575 ~ 1584 [2012]
  • Hypersensitivity reactions to oxaliplatin: experience in a single institute
    Siu SW Ann Oncol 17 : 259 ~ 261 [2006]
  • Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule
    Meyer L J Clin Oncol 20 : 1146 ~ 1147 [2002]
  • Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans
    Kim MY Asian Pac J Cancer Prev 13 : 1209 ~ 1215 [2012]
  • Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol
    Gammon D Oncologist 9 : 546 ~ 549 [2004]
  • Hypersensitivity reactions to oxaliplatin and other antineoplastic agents
    Syrigou E Curr Allergy Asthma Rep 8 : 56 ~ 62 [2008]
  • Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol
    Syrigou E Int Arch Allergy Immunol 156 : 320 ~ 324 [2011]
  • Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases
    Castells MC J Allergy Clin Immunol 122 : 574 ~ 580 [2008]
  • Hypersensitivity reactions to antineoplastic agents: an overview
    Syrigou E Anticancer Drugs 20 : 1 ~ 6 [2009]
  • Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review
    Makrilia N Met Based Drugs : 207084 ~ [2010]
  • Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel
    Denman JP J Clin Oncol 20 : 2760 ~ 2761 [2002]
  • High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
    Kidera Y Int J Clin Oncol 16 : 244 ~ 249 [2011]
  • Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions
    Szebeni J Int Immunopharmacol 1 : 721 ~ 735 [2001]
  • Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction
    Berger MJ Support Care Cancer 20 : 1991 ~ 1997 [2012]
  • Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia
    Vrooman LM Pediatr Blood Cancer 54 : 199 ~ 205 [2010]
  • Effectiveness of oxaliplatin desensitization protocols
    Cortijo-Cascajares S Clin Transl Oncol 15 : 219 ~ 225 [2013]
  • Effective desensitization protocol to paclitaxel following hypersensitivity reaction
    Fishman A Int J Gynecol Cance 9 : 156 ~ 159 [1999]
  • Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin
    Decorti G Anticancer Res 16 : 317 ~ 320 [1996]
  • Drug hypersensitivity
    Solensky R Med Clin North Am 90 : 233 ~ 260 [2006]
  • Docetaxel: a taxoid for the treatment of metastatic breast cancer
    Tankanow RM Am J Health Syst Pharm 55 : 1777 ~ 1791 [1998]
  • Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents
    Lee C Ann Allergy Asthma Immunol 102 : 179 ~ 187 [2009]
  • Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?
    Schwartz JR J Oncol Pharm Pract 18 : 250 ~ 256 [2012]
  • Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer
    Nozawa H Clin Ther 30 : 1160 ~ 1165 [2008]
  • Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
    Weiszh?r Z Eur J Pharm Sci 45 : 492 ~ 498 [2012]
  • Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
    Weiszhár Z Eur J Pharm Sci 45 : 492 ~ 498 [2012]
  • Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study
    Szebeni J J Natl Cancer Inst 90 : 300 ~ 306 [1998]
  • Clinical toxicities encountered with paclitaxel (Taxol)
    Rowinsky EK Semin Oncol 20 (4 Suppl 3) : 1 ~ 15 [1993]
  • Clinical features of hypersensitivity reactions to carboplatin
    Markman M J Clin Oncol 17 : 1141 ~ [1999]
  • Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer
    Smith IE Cancer Treat Rep 69 : 43 ~ 46 [1985]
  • Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions
    Lee CW Gynecol Oncol 95 : 370 ~ 376 [2004]
  • An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions
    Markman M J Cancer Res Clin Oncol 125 : 427 ~ 429 [1999]
  • Allergic reactions to oxaliplatin in a single institute in Japan
    Ichikawa Y Jpn J Clin Oncol 39 : 616 ~ 620 [2009]
  • A new rapid desensitization protocol for chemotherapy agents
    Gastaminza G J Investig Allergol Clin Immunol 21 : 108 ~ 112 [2011]
  • A desensitization protocol in children with L-asparaginase hypersensitivity
    Akbayram S J Pediatr Hematol Oncol 32 : 187 ~ 191 [2010]